Marijuana Rescheduling and Therapeutic Cannabis Use
The federal government is actively considering rescheduling marijuana from a Schedule I to a Schedule III controlled substance, a move that would acknowledge its medical value and significantly ease restrictions on research, taxation, and access. This shift could transform cannabis from a stigmatized drug into a regulated therapeutic option, paving the way for expanded clinical trials and FDA oversight of treatments for conditions like chronic pain, epilepsy, and multiple sclerosis.
During this session, the panelists will discuss how this outcome could redefine cannabis’s role in medicine, law, and the economy
Related Professional
